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a  b  s  t  r  a  c  t
GABAA and  GABAB receptors  activation  with  agonists  muscimol  and  baclofen,  respectively  in the lat-
eral  parabrachial  nucleus  (LPBN),  induces  water  and  hypertonic  NaCl  intake  in  rats.  The  purpose  of  this
study  was  to  examine  the  effects  of previous  injections  of  losartan  (AT1 angiotensin  receptor  antago-
nist)  into  the  LPBN  on  0.3  M  NaCl  and  water  intake  induced  by  baclofen  injected  bilaterally  in the  same
area  in  ﬂuid  replete  rats  and  in  rats  treated  with  the diuretic  furosemide  combined  with  a low  dose  of
the angiotensin-converting  enzyme  inhibitor  captopril  injected  subcutaneously.  Male  Wistar  rats  with
stainless  steel  cannulas  implanted  bilaterally  into  the  LPBN  were  used.  Bilateral  injections  of  baclofen
(0.5  nmol/0.2  l, n  =  6) into  the  LPBN  in ﬂuid  replete  rats  induced  0.3  M NaCl  intake  (22.4  ± 6.5 vs.  saline:
0.1  ± 0.1  ml/210  min)  and  water  intake  (14.2  ± 4.0  vs.  saline:  0.6  ±  0.6  ml/210  min)  and  pre-treatment  of
the LPBN  with  losartan  (50  g/0.2  l)  reduced  0.3  M  NaCl  intake  (7.4  ± 7.0  ml/210  min)  and  water  intake
(2.8  ± 2.4  ml/210  min)  induced  by  baclofen.  In  rats  treated  with  furosemide  + captopril,  pre-treatmenthirst
ateral parabrachial nucleus
with  losartan  into  the  LPBN  attenuated  the  increase  in  0.3  M  NaCl  intake  (13.3  ±  3.2 vs. saline  +  baclofen:
24.3  ± 3.9  ml/180  min)  and  water  intake  (4.8  ± 2.1  vs. saline  + baclofen:  19.5  ±  6.6  ml/180  min)  produced
by  baclofen.  We  conclude  that baclofen  may  produce  a non-speciﬁc  blockade  of the  inhibitory  mech-
anisms  of  LPBN  (deactivation  of  LPBN  inhibitory  mechanisms)  and  this  blockade  is  facilitated  by
angiotensin  II  acting  on  AT1 receptors  in  the  LPBN,  which  drives  rats  to  ingest  large  amounts  of  water
and  hypertonic  NaCl  independent  if  rats  are  ﬂuid  depleted  or normohydrated.. Introduction
The lateral parabrachial nucleus (LPBN), a pontine structure that
ies dorsal to the superior cerebellar peduncle (SCP) is an important
rea involved in the control of water and sodium intake [4,13,31].
he LPBN receives afferent projections from the area postrema
AP) and the medial portion of the nucleus of the solitary tract
mNTS), and it sends efferent projections to areas of the forebrain,
uch as the paraventricular nucleus of the hypothalamus (PVN), the
Abbreviations: ANG II, angiotensin II; AHA, anterior hypothalamic area; CRF,
orticotropin-releasing hormone; CNS, central nervous system; FURO, furosemide;
AP, captopril; IPSCs, inhibitory post-synaptic currents; LPBN, lateral parabrachial
ucleus; SCP, superior cerebellar peduncle; NTS, nucleus of the solitary tract; PVN,
araventricular nucleus of the hypothalamus; CeA, central nucleus of the amygdala;
nPO, median preoptic nucleus.
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ax: +55 18 3636 3332.
E-mail address: jocaller@foa.unesp.br (J.C. Callera).
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central nucleus of the amygdala (CeA) or the median preoptic
nucleus (MnPO) [21–23].
The cardiovascular, neuroendocrine and ingestive effects of ANG
II acting centrally are mediated mainly by angiotensin type 1 (AT1)
receptors located in different areas of the central nervous system,
such as the LPBN, anterior hypothalamic area (AHA), amygdala and
SFO [16,28,38].
It has been reported that ANG II acting on AT1 receptors may
modulate GABAergic synaptic transmission producing opposite
effects, depending on whether pre- or post-synaptic AT1 receptors
are activated. Studies showed that ANG II acting on pre-synaptic
AT1 receptors reduces GABA release and decreases the ampli-
tude of evoked GABAergic inhibitory post-synaptic currents (IPSCs)
[26,27,40]. In contrast, the amplitude of muscimol-activated GABAA
currents in the median preoptic nucleus was reduced by the treat-
ment with losartan, the nonpeptide antagonist that selectively
binds on AT1 receptors, suggesting a post synaptic action of endoge-
nous ANG II that facilitated the effect of the GABAergic input to
Open access under the Elsevier OA license.the MnPO [20]. In addition, other studies showed that central
administration of ANG II stimulates GABAB receptor expression
and augments GABAB receptor-mediated responses in neuronal
cultures from the nucleus tractus solitarii [42,43].
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A dense plexus of GABA-immunoreactive varicosities exists in
he parabrachial nucleus [19]. It was also already shown the pres-
nce of GABAA and GABAB receptors in the LPBN [3,5].
The blockade of LPBN neurons with bilateral injections of the
ABAA and GABAB agonists muscimol and baclofen, respectively
nduces ingestion of hypertonic NaCl and water in ﬂuid replete rats
4,13].  In addition, injections of muscimol into the LPBN increases
URO + CAP- and 24 h of sodium depletion-induced sodium intake,
uggesting that a GABAergic mechanism present in LPBN is involved
n the control of sodium intake [4,10,13].
A recent study [8],  showed that the blockade of AT1 receptor
ntagonist with bilateral injection of losartan into the LPBN reduced
.3 M NaCl and water intake induced by GABAA receptor activa-
ion with muscimol injected into the same area, suggesting that
he deactivation of LPBN inhibitory mechanisms by muscimol is
acilitated by angiotensin II acting on AT1 receptors in the LPBN.
Considering the effects of activation of GABAB receptors in the
PBN on hypertonic NaCl and water intake, the results of previous
tudies showing that ANG II augments GABAB receptor-mediated
esponses, AT1 receptor activation may  modulate the action of the
ABAergic mechanisms and injection of losartan into the LPBN
educed sodium intake induced by muscimol injected into the same
rea in rats, in the present study we investigated the effects of
njections of losartan into the LPBN on water and hypertonic NaCl
ntake induced by the activation of GABAB receptors by baclofen
njections into the LPBN in ﬂuid replete or FURO + CAP-treated
ats.
. Material and methods
.1. Animals
Male Wistar rats weighing 290–310 g were used. The animals were housed in
ndividual stainless steel cages with free access to normal sodium diet (Guabi Rat
how, Paulinia, SP, Brazil), water and 0.3 M NaCl solution. The positions of the bottles
ontaining water and 0.3 M NaCl were rotated daily to avoid place preference. Room
emperature was  maintained at 23 ± 2 ◦C and humidity was  maintained at 55 ± 10%
n  a 12:12 light–dark cycle with light onset at 07:30 am.
The procedures were approved by the Institutional Ethical Committee for Ani-
al  Care from the School of Dentistry, UNESP, Arac¸ atuba, Brazil (Proc. CEEA no.
86/2007) and followed the recommendations from the Brazilian College of Ani-
al Experimentation (COBEA) and the American National Institute of Health Guide
or  the Care and Use of Laboratory Animals (NIH publications No. 80-23, 1996,
SA).
All efforts were made to minimize animal discomfort and the number of animals
sed.
.2. Cerebral cannulas
Rats were anesthetized with subcutaneous (sc) ketamine (80 mg/kg of body
eight, Cristália, Brazil) combined with xylazine (7 mg/kg of body weight, Agener,
razil) and placed in a stereotaxic instrument (Kopf, USA). The skull was  leveled
etween bregma and lambda. Stainless steel guide-cannulas (12 mm × 0.6 mm o.d)
ere implanted bilaterally into the LPBN using the following coordinates: 9.2 mm
audal to bregma, 2.2 mm lateral to the midline, and 3.8 mm below the dura mater
36].  The tips of the cannulas were positioned 2 mm above each LPBN. The can-
ulas were ﬁxed to the cranium using dental acrylic resin and jeweler screws.
0-Gauge metal obturators ﬁlled the cannulas between tests. After the surgery, the
ats received intramuscular injections of the analgesic cetoprophen 1% (0.03 ml)
nd  a prophylactic dose of the antibiotic penicillin (30,000 IU). Rats were allowed
o  recover for 5 days before starting ingestion tests and during this period they had
ree  access to standard sodium diet, water and 0.3 M NaCl solution.
.3.  Injections into the LPBN
Bilateral injections into the LPBN were made using 5-l  Hamilton syringes con-
ected by polyethylene tubing (PE-10) to 30-gauge injection cannulas. At the time
f  testing, obturators were removed, the injection cannula (2 mm longer than the
uide cannula) was  carefully inserted into the guide cannula. For bilateral injections,
he  ﬁrst injection was performed on one side, the needle was removed and repo-
itioned on the contra lateral side, and then the second injection made. Therefore
njections were made ∼1 min  apart. The injection volume into the LPBN was  0.2 l
n  each site. The obturators were replaced after the injections, and the rats were
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2.4. Drugs
Furosemide (FURO) (Sigma–Aldrich, Saint Louis, MO,  USA) was dissolved in alka-
line saline (pH adjusted to 9.0) and administered sc at the dose of 10 mg/kg of body
weight (bw). Captopril (CAP) (Sigma–Aldrich, Saint Louis, MO,  USA), was dissolved
in  0.15 M NaCl and administered sc at the dose of 5 mg/kg of bw.
Losartan potassium and (±)-Baclofen (Sigma–Aldrich, Saint Louis, MO,  USA)
were dissolved in 0.15 M NaCl. The dose of baclofen used in the present study was
the same as that used in previous studies that investigated the effects of baclofen
injected into the LPBN on water and 0.3 M NaCl intakes [12,13]. This dose of baclofen
produces a long-lasting action (at least for 3 h) when injected into the LPBN [13].
The dose of losartan was based on previous studies that have tested the effects of
central or LPBN injections of losartan on water and 0.3 M NaCl intake induced by
ANG II or muscimol [8,18,34]. The dose of losartan used is effective for at least 2 h
[8,34].
2.5.  Water and 0.3 M NaCl intake by ﬂuid replete rats
The rats were tested in their home cages. Water and 0.3 M NaCl were pro-
vided from burettes with 0.1-ml divisions that were ﬁtted with metal drinking
spouts. Food was  not available during the tests. Measurements were taken at 30-
min  intervals for 210 min, starting 10 min after bilateral injections of baclofen
(0.5 nmol/0.2 l) or saline (0.2 l) into the LPBN.
Fluid replete rats that received no pre-treatment (n = 14), were tested for the
effects of the combination of losartan and baclofen injections into the LPBN on
water and 0.3 M NaCl intake. Losartan (50 g/0.2 l) was injected into the LPBN
10  min  before baclofen (0.5 nmol/0.2 l). These rats were submitted to four tests
and  received the following combinations of treatments into the LPBN: saline + saline,
saline + baclofen, losartan + baclofen and losartan + saline. In each test, the group of
rats was divided in two and half of the group received one of the combination of
treatments listed above, while the remaining animals received another combination
of  treatments into the LPBN. The sequence of the treatments was randomized for
each rat so that, at the end of testing, rats had received all four treatments. All tests
began between 13:00 pm and 15:00 pm.  A recovery period of at least 2 days was
allowed between tests.
2.6. Water and 0.3 M NaCl intake by FURO + CAP-treated rats
Another group of rats (n = 15) was used to test water and 0.3 M NaCl intake
induced by treatment with FURO + CAP sc. On the day of the experiment, food, water
and  0.3 M NaCl were removed and the cages were rinsed with water. Rats received
sc  injections of the diuretic FURO (10 mg/kg bw)  plus CAP (5 mg/kg bw) as described
previously [8,30,39]. One hour after FURO + CAP treatment, burettes with water and
0.3 M NaCl solution were returned and measurements were taken at 30-min inter-
vals for 210 min  (sodium appetite test). Ten minutes before access to water and 0.3 M
NaCl, rats received bilateral injections of baclofen (0.5 nmol/0.2 l) or saline into
the  LPBN. Bilateral injections of losartan (50 g/0.2 l) or saline into the LPBN were
performed 10 min  before the injections of baclofen or saline into the LPBN. In each
experimental session, the group of rats was divided in two and each half of the group
received one of the four treatments in the LPBN: saline + saline, saline + baclofen,
losartan + baclofen and losartan + saline. The sequence of the treatments was in a
randomized order so that at the end of testing, rats had received all four treatments.
A recovery period of at least 3 days was allowed between experimental sessions. All
tests began between 13:00 pm and 15:00 pm.
The order of treatments was randomized because repeated FURO + CAP injec-
tions enhances stimulated and spontaneous NaCl intake [37].
2.7. Histology
At the end of the experiments, the animals received bilateral injections of 2%
Evans blue dye solution (0.2 l/injection site) into the LPBN. They were then deeply
anesthetized with sodium thiopental (CRISTALIA, Itapira, SP, Brazil, 80 mg/kg of body
weight) and perfused transcardially with saline followed by 10% formalin. The brains
were  removed, ﬁxed in 10% formalin, frozen, cut in 60 m sections, stained with
Giemsa, and analyzed by light microscopy to conﬁrm the speciﬁcity of the LPBN
as  the site of injections of baclofen that produce the effects on water and sodium
intake.
2.8. Statistical analysisThe results are reported as means ± S.E.M. Water and 0.3 M NaCl intake were
analyzed by two-way analysis of variance (ANOVA) with repeated measures for
both factors (treatments and times), followed by Newman–Keuls post hoc test. Dif-
ferences were considered signiﬁcant at P < 0.05. The software used to analyze the
data was  SigmaStat for Windows, version 2.03 from SPSS Inc.
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Table 1
Ingestion of water and 0.3 M NaCl by ﬂuid replete rats or FURO + CAP-treated rats
that received saline or losartan combined with saline or baclofen in sites outside the
LPBN (misplaced injections).
Fluid replete rats
(n = 8)
0.3 M NaCl
intake (ml/3 h)
Water intake
(ml/3 h)
Saline + saline 0.1 ± 0.1 0.2 ± 0.1
Saline + baclofen 2.6 ± 1.5 2.2 ± 1.4
Losartan + baclofen 2.3 ± 1.8 2.3 ± 1.5
Losartan + saline 0.5 ± 0.4 1.9 ± 1.6
FURO + CAP-treated rats
(n = 9)
0.3 M NaCl
intake (ml/3 h)
Water intake
(ml/3 h)
Saline + saline 6.7 ± 4.9 10.5 ± 2.0
Saline + baclofen 3.6 ± 1.6 6.9 ± 3.5
Losartan + baclofen 6.2 ± 2.9 6.3 ± 3.3
Losartan + saline 5.5 ± 2.3 8.2 ± 1.6
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oalues are means ± S.E.M. n = Number of rats. Losartan (50 g/0.2 l); baclofen
0.5  nmol/0.2 l).
. Results
.1. Histological analysis
Fig. 1 is a photomicrograph of a transverse section of the brain-
tem of one rat, representative of the groups tested, showing the
ypical bilateral injection sites in the LPBN. The injections were cen-
ered in the central lateral and dorsal lateral portions of the LPBN
see Ref. [17] for deﬁnitions of LPBN subnuclei). In some rats, LPBN
njections reached the ventral lateral and external lateral portions,
s well as the Kölliker–Fuse nucleus. The sites of injections were
imilar to those in previous studies that showed the effects of LPBN
njections of methysergide, moxonidine, muscimol or baclofen on
ater and 0.3 M NaCl intake [2,8,13]. In some rats, injections spread
o the brachium (superior cerebellar peduncle), or slightly ven-
ral to this structure, reaching the dorsal portions of the medial
arabrachial nucleus (MPBN) uni-or bilaterally. There was no dif-
erence in the effects if the injections were restricted to the LPBN
r if they spread to the ventral structures described above.
Rats in which injections did not reach the LPBN (misplaced
njections) were excluded from the analyses of data presented in
igs. 2 and 3 and the values of their intakes are presented in Table 1.
ig. 1. Photomicrograph of a brain slice from one rat representative of the groups studied
utline  the superior cerebellar peduncles (SCP). Bulletin 86 (2011) 348– 354
Bilateral injections of baclofen or losartan alone or of baclofen
combined with losartan in sites outside the LPBN did not affect
water and 0.3 M NaCl intake in ﬂuid replete rats or FURO + CAP-
treated rats. ANOVA showed no signiﬁcant differences between
treatments for 0.3 M NaCl intake [F(3,21) = 1.0; P > 0.05] or water
intake [F(3,21) = 0.8; P > 0.05] in ﬂuid replete rats or between treat-
ments for 0.3 M NaCl intake [F(3,24) = 0.6; P > 0.05] or water intake
[F(3,24) = 3.3; P > 0.05] in FURO + CAP-treated rats that received
injections in sites outside the LPBN.
Misplaced injections were ventral (MPBN), dorsal or rostral to
the LPBN. Some rats had unilateral injections partially into the
LPBN.
3.2. Effects of combined injections of losartan and baclofen into
the LPBN on water and 0.3 M NaCl intake in ﬂuid replete rats
ANOVA showed signiﬁcant differences between treatments and
time for 0.3 M NaCl intake [F(18,90) = 4.1; P < 0.001] and water
intake [F(18,90) = 5.1; P < 0.001] in ﬂuid replete rats that received
injections of saline or losartan combined with injections of saline
or baclofen into the LPBN (Fig. 2).
In two-bottle tests, bilateral injections of baclofen
(0.5 nmol/0.2 l at each site, n = 6) into the LPBN in ﬂuid
replete rats induced 0.3 M NaCl intake (22.4 ± 6.5 ml/210 min, vs.
saline + saline: 0.1 ± 0.1 ml/210 min, Fig. 2A and B) and water intake
(14.2 ± 4.0 ml/210 min, vs. saline + saline: 0.6 ± 0.6 ml/210 min,
Fig. 2C and D). Previous injections of the AT1 receptor antagonist
losartan (50 g/0.2 l each site) into the LPBN reduced the effects
of baclofen (0.5 nmol/0.2 l) injected in the same area on 0.3 M
NaCl intake (7.4 ± 7.0 ml/210 min, Fig. 2A and B) and water intake
(2.8 ± 2.4 ml/210 min, Fig. 2C and D).
The ingestion of 0.3 M NaCl and water after bilateral injections
of baclofen into the LPBN in replete rats was signiﬁcantly differ-
ent from those after saline injected into the LPBN (control) from
150 min  to the end of the test (210 min) and the pre-treatment with
losartan injected into the LPBN reduced the ingestion of water in the
same period (Fig. 2C and D). Pre-treatment with losartan reduced
the ingestion of 0.3 M NaCl induced by baclofen from 180 to 210 min
of the test (Fig. 2A and B). Losartan injected alone into the LPBN did
not affect water or 0.3 M NaCl intake.
 showing site of injection into the lateral parabrachial nucleus (LPBN, arrows). Dots
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rig. 2. (A) Cumulative 0.3 M NaCl intake; (B) individual 0.3 M NaCl intakes (210 min
reated with losartan (50 g/0.2 l) or saline combined with baclofen (0.5 nmol/0.2
ats.  *Different from saline + saline; +different from saline + baclofen 0.5 nmol.
.3. Effects of combined injections of losartan and baclofen into
he LPBN on FURO + CAP-induced 0.3 M NaCl and water intake
ANOVA showed signiﬁcant interactions between treatments
nd times for 0.3 M NaCl intake [F(18,90) = 7.5; P < 0.001] and for
ater intake [F(18,90) = 3.2; P < 0.001] induced by FURO + CAP in
ats that received injections of saline or losartan combined with
njections of saline or baclofen into the LPBN (Fig. 3).
Bilateral injections of baclofen (0.5 nmol/0.2 l at each site,
 = 6) into the LPBN increased FURO + CAP-induced 0.3 M NaCl
ntake from 120 min  to the end of the test (24.8 ± 3.7 ml/210 min,
s. saline + saline: 3.9 ± 2.3 ml/210 min) (Fig. 3A and B) and
ncreased FURO + CAP-induced water intake from 180 min  to
he end of the test (21.1 ± 6.2 ml/210 min, vs. saline + saline:
0.9 ± 2.5 ml/210 min) (Fig. 3C and D). Losartan (50 g/0.2 l
t each site) injected into the LPBN reduced the effects of
aclofen on 0.3 M NaCl intake from 120 to 180 min  of the test
13.3 ± 3.2 ml/180 min, Fig. 3A and B) and reduced the effects of
aclofen on water intake from 150 min  to the end of the test
5.1 ± 2.2 ml/210 min, Fig. 3C). Losartan injected alone into the
PBN produced no change in FURO + CAP-induced 0.3 M NaCl and
ater intake compared to the treatment with saline (Fig. 3A and C).
. DiscussionSimilar to previous study [13], the present study shows that
ilateral injections of baclofen (GABAB receptor agonist) into the
PBN induce water and hypertonic NaCl ingestion in ﬂuid replete
ats. The present study also show that baclofen injected into theumulative water intake; (D) individual water intakes (210 min) by ﬂuid replete rats
 saline bilaterally into the LPBN. (A and C) Values are means ± S.E.M. n = Number of
LPBN increase 0.3 M NaCl and water intake in FURO + CAP-treated
rats. The involvement of GABAB receptors of the LPBN in the con-
trol of NaCl intake is supported by a previous study showing that
the GABAB receptor antagonist (CGP 35348 or 2-hydroxysaclofen)
injected into the LPBN was able to reduce the natriorexigenic effect
of baclofen injected into the LPBN in ﬂuid replete rats, which sug-
gests that the activation of GABAB receptor is necessary for the
natriorexigenic effect of baclofen [13]. The present results extend
the conclusions of the previous study by showing that pretreat-
ment of the LPBN with bilateral injections of the nonpeptide AT1
receptor antagonist losartan reduce water and 0.3 M NaCl intake
caused by baclofen injected into the same site in ﬂuid replete rats,
as well as the increase in water and 0.3 M NaCl produced by baclofen
injected bilaterally into the LPBN in FURO + CAP-treated rats. Injec-
tions of losartan alone into the LPBN did not change water or 0.3 M
NaCl intake by untreated rats or FURO + CAP-treated rats. Results
from rats with misplaced injections conﬁrm that baclofen effects on
water and 0.3 M NaCl intake are speciﬁc to the LPBN. The results also
suggest that angiotensinergic mechanisms in the LPBN are essen-
tial for the dipsogenic and natriorexigenic responses induced by
the blockade of LPBN neurons with baclofen in ﬂuid replete rats or
FURO + CAP-treated rats.
Pretreatment with losartan into the LPBN reduced baclofen
effects on water and NaCl intake by ﬂuid replete or FURO + CAP-
treated rats. Therefore, if endogenous GABA release in the LPBN was
important for FURO + CAP-induced water and sodium intake, simi-
lar effects would be expected when losartan alone was injected in
FURO + CAP-treated rats. However, injections of losartan alone did
not modify FURO + CAP-induced water or NaCl intake, suggesting
that GABA release or its interaction with activated AT1 receptors
352 C.Z.C. Da Silva et al. / Brain Research Bulletin 86 (2011) 348– 354
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rig. 3. (A) Cumulative 0.3 M NaCl intake; (B) individual 0.3 M NaCl intakes (180 m
reated  rats that received losartan (50 g/0.2 l) or saline combined with baclofen
 = number of rats. *Different from saline + saline. +Different from saline + baclofen 0
n the LPBN is not essential for sodium or water intake induced by
URO + CAP. Perhaps any reduction of GABA effects by losartan was
ompensated for by changes in the release of other neurotransmit-
ers in the LPBN like serotonin, CCK or opioids that also modulate
ater and sodium intake [9,11,30,31].
AT1 receptors and ANG II terminals are present in the LPBN
25,29]. The present results suggest that ANG II acting on AT1
eceptors in the LPBN is necessary for the full effects of baclofen
njected into the LPBN on water and NaCl intake. The treatment
ith FURO + CAP increases ANG II centrally [39]. However, it is
ossible that activation of AT1 receptors by the baseline levels of
NG II in ﬂuid replete rats is sufﬁcient to facilitate the increase
n water and sodium intake produced by baclofen in the LPBN.
n the other hand, although there is no evidence that injections
f baclofen into the LPBN increase ANG II levels, with the present
esults do not allow us to exclude the possibility of an increase in
entral or peripheral levels of ANG II due to baclofen injections into
he LPBN. The ingestion of sodium after baclofen injections into the
PBN takes at least 2 h to start, which is a time enough for changes
n the levels of ANG II that acting in the LPBN may  intensify the
ffects of baclofen on LPBN neurons, a step necessary for the release
f sodium intake.
The cardiovascular, neuroendocrine and ingestive effects of ANG
I acting centrally are mediated mainly by AT1 receptors [16,28,38].
or example, ingestion of water and NaCl is suggested to depend
n the action of circulating ANG II on circumventricular organs like
he SFO and OVLT [24,35].  At the same time, AT1 receptors have a
ole in mediating an enhanced sodium intake produced by blockade) cumulative water intake; (D) individual water intakes (180 min) by FURO + CAP-
mol/0.2 l) or saline bilaterally into the LPBN. (A and C) Values are means ± S.E.M.
ol.
of LPBN inhibitory mechanisms with injections of the serotoner-
gic antagonist methysergide [7,32].  More speciﬁcally, injections
of methysergide into the LPBN combined with treatments that
increase ANG II centrally or peripherally, such as FURO + CAP sc,
isoproterenol or acute (1 h previous) treatment with FURO, also
produce robust ingestion of 0.3 M NaCl [31,33].  Whereas treatment
with FURO + CAP alone induces signiﬁcant ingestion of NaCl, sc
treatments with isoproterenol or acute furosemide do not produce
signiﬁcant ingestion of NaCl, despite increases in ANG II signal-
ing, unless LPBN inhibitory mechanisms are deactivated. Therefore,
sodium intake does not always increase even with increased levels
of ANG II. However, if the LPBN inhibitory mechanisms are deac-
tivated, then ANG II-induced sodium and water intake is strongly
facilitated.
In addition to methysergide, the blockade of other neurotrans-
mitters in the LPBN like CCK, glutamate, or the activation of 2
adrenoceptors with noradrenaline or moxonidine, deactivate LPBN
inhibitory mechanisms and increase sodium and water intake
induced by the treatment with FURO + CAP [1,9,30,31]. The block-
ade of these neurotransmitters or activation of 2 adrenoceptors
in the LPBN produces no sodium or water intake in ﬂuid replete
rats that might suggest that sodium intake easily arises only when
facilitatory mechanism are activated and inhibitory mechanisms
are simultaneously deactivated. However, in contrast to the block-
ade of the other neurotransmitters or 2 adrenoceptor activation,
either opioid ( endorphin) or GABAergic (muscimol and baclofen)
activation of the LPBN induces robust ingestion of water and 0.3 M
NaCl in ﬂuid replete rats, suggesting that the deactivation of LPBN
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nhibitory mechanisms alone is sufﬁcient to disrupt satiety and
o drive rats to ingest hypertonic NaCl [4,10,11,13]. The present
esults also show an increased sodium intake 2 h after baclofen
nto the LPBN in FURO + CAP-treated rats. The effects of baclofen
nto the LPBN on sodium intake are not secondary to decreases
n blood pressure or an increase on sodium urinary excretion
13].
The ingestion of hypertonic NaCl solutions increases the activity
f LPBN neurons, suggesting that the LPBN can be activated by taste
nd/or visceral stimuli [15,41]. Signals from volume, taste and other
isceral receptors that may  participate in the control of water and
odium intake reach the AP/mNTS before ascending to the LPBN
hat, in turn, sends projections to forebrain areas involved in the
ontrol of ﬂuid and electrolyte balance, such as the SFO, MnPO,
VN and amygdala [6,22,35].
AT1 receptors are present in different areas of the brain, includ-
ng the LPBN [14,28]. Acting on AT1 receptors, ANG II may  modulate
ABAergic neurotransmission producing opposite effects if pre- or
ost-synaptic AT1 receptors are activated. It has been suggested
hat ANG II acting on pre-synaptic AT1 receptors reduces GABA
elease and decreases the amplitude of evoked GABAergic IPSCs
26,27,40]. In contrast, it was shown that ANG II acting on post-
ynaptic AT1 receptors increases IPSCs in sodium-sensitive neurons
n the MnPO [20]. In addition, in a recent study [8] showed that
he blockade of AT1 receptors with injection of losartan into the
PBN reduced 0.3 M NaCl and water intake induced by muscimol
njected into the same area, suggesting that the deactivation of
PBN inhibitory mechanisms by GABAA receptor activation is facil-
tated by angiotensin II acting on AT1 receptors in the LPBN.
Similar to previous study [8],  the present results show that the
lockade of AT1 receptors by the injection of losartan into the LPBN
lso reduces hypertonic NaCl and water intake stimulated by the
ctivation of LPBN GABAB receptors with baclofen injected in the
ame area in ﬂuid replete or in FURO + CAP-treated rats. We  suppose
hat baclofen may  produce a non-speciﬁc blockade of the inhibitory
echanisms (deactivation of LPBN inhibitory mechanisms), i.e.,
aclofen might block all the signals that reach the LPBN and in this
ondition sodium intake is released independent if animals are ﬂuid
epleted or normohydrated. More studies are necessary to investi-
ate which signals that reach the LPBN are involved in the control
f sodium intake and if different neurotransmitters in the LPBN are
elated to different signals.
The present results suggest that ANG II acting on post-synaptic
T1 receptors in the LPBN facilitates the effects of GABAB activa-
ion with baclofen via a mechanism similar to that described in
he MnPO [20]. Therefore, the results of present study suggest that
nteractions of angiotensinergic and GABAergic mechanisms in the
PBN are important to stimulate water and sodium intake. In other
ords, the action of ANG II on AT1 receptors in the LPBN is impor-
ant for the inhibition of LPBN neurons, thereby facilitating water
nd hypertonic NaCl intake produced by activation of GABAA and
ABAB receptors in the LPBN.
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